Establishment of program
- • rules
- • report to commission
(1)(a) The Oregon Health Authority, in consultation with the Prescription Monitoring Program Advisory Commission, shall establish and maintain a prescription monitoring program for monitoring and reporting:
(A) Prescription drugs dispensed by pharmacies licensed by the State Board of Pharmacy that are classified in schedules II through IV under the federal Controlled Substances Act, 21 U.S.C. 811 and 812, as modified by the board by rule under ORS 475.035 (Authority to control schedule); and
(B) Prescribed naloxone dispensed by pharmacies.
(b)(A) To fulfill the requirements of this subsection, the authority shall establish, maintain and operate an electronic system to monitor and report drugs described in paragraph (a) of this subsection that are dispensed by prescription.
(B) The electronic system must operate and be accessible by practitioners and pharmacies 24 hours a day, seven days a week.
(C) The authority may contract with a state agency or private entity to ensure the effective operation of the electronic system.
(2) In consultation with the commission, the authority shall adopt rules for the operation of the electronic prescription monitoring program established under subsection (1) of this section, including standards for:
(a) Reporting data;
(b) Providing maintenance, security and disclosure of data;
(c) Ensuring accuracy and completeness of data;
(d) Complying with the federal Health Insurance Portability and Accountability Act of 1996 (P.L. 104-191) and regulations adopted under that law, including 45 C.F.R. parts 160 and 164, federal alcohol and drug treatment confidentiality laws and regulations adopted under those laws, including 42 C.F.R. part 2, and state health and mental health confidentiality laws, including ORS 179.505 (Disclosure of written accounts by health care services provider), 192.517 (Access to records of individual with disability or individual with mental illness) and 192.553 (Policy for protected health information) to 192.581 (Allowed retention or disclosure of genetic information);
(e) Ensuring accurate identification of persons or entities requesting information from the database;
(f) Accepting printed or nonelectronic reports from pharmacies that do not have the capability to provide electronic reports; and
(g) Notifying a patient, before or when a drug classified in schedules II through IV is dispensed to the patient, about the prescription monitoring program and the entry of the prescription in the electronic system.
(3) The authority shall submit an annual report to the commission regarding the prescription monitoring program established under this section. [Formerly 431.962; 2017 c.683 §12]
3 OregonLaws.org assembles these lists by analyzing references between Sections. Each listed item refers back to the current Section in its own text. The result reveals relationships in the code that may not have otherwise been apparent.